Opportunity ID: 236600

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-GM-14-010
Funding Opportunity Title:: Drug Docking and Screening Data Resource (U01)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards:: 1
Assistance Listings Number(s):: 93.859 — Biomedical Research and Research Training
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 2
Posted Date:: Jun 19, 2013
Last Updated Date:: Oct 18, 2013
Original Closing Date for Applications:: Oct 09, 2013
Current Closing Date for Applications:: Nov 01, 2013
Archive Date:: Dec 01, 2013
Estimated Total Program Funding:: $ 750,000
Award Ceiling:: $500,000
Award Floor:: $

Eligibility

Eligible Applicants:: City or township governments
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: The purpose of this Funding Opportunity Announcement (FOA) is to continue to increase the amount of publicly available, high-quality data describing structures and affinities of protein-drug ligand complexes -data vital for development, validation, and benchmarking of drug docking and screening software. Accurate and robust methods for in silico drug screening are expected to speed drug discovery and reduce drug development cost by focusing experimental efforts on the most promising candidate compounds. The ability to predict side effects resulting from off-target binding and to increase repurposing of existing pharmaceuticals is an additional expected benefit.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 2 Modified Archive Date based on new Expiration Date, per NOT-OD-14-003. Oct 18, 2013
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings: 93.859
Competition ID: FORMS-C
Competition Title: Use for due dates after 9/24/2013
Opportunity Package ID: PKG00179811
Opening Date: Sep 09, 2013
Closing Date: Nov 01, 2013
Agency Contact Information:: eRA Commons Help Desk
Who Can Apply:: Organization Applicants
mendatory_forms SF424 (R & R) [V2.0]
PHS 398 Research Plan [V2.0]
PHS 398 Cover Page Supplement [V2.0]
Research and Related Senior/Key Person Profile (Expanded) [V2.0]
Research And Related Other Project Information [V1.3]
Project/Performance Site Location(s) [V2.0]
optional_forms R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.3]
Planned Enrollment Report [V1.0]
PHS 398 Cumulative Inclusion Enrollment Report [V1.0]
PHS 398 Modular Budget [V1.2]
Research & Related Budget [V1.3]

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Agency Contact Information: Who Can Apply:
93.859 FORMS-C Use for due dates after 9/24/2013 PKG00179811 Sep 09, 2013 Nov 01, 2013 View eRA Commons Help Desk Organization Applicants

Related Documents